News | July 05, 2011

Swedish Hospital Welcomes Country's First TrueBeam Radiotherapy System

July 5, 2011 — Cancer patients in Sweden have gained access to fast and efficient radiotherapy treatments with the installation of Scandinavia's first TrueBeam system from Varian Medical Systems. This advanced system has commenced clinical treatments for patients at Vasteras Hospital, west of Stockholm.

Until recently, physicists and doctors at the busy hospital have been treating 70 patients a day in two shifts between 6:30 a.m. and 8:30 p.m. The arrival of the TrueBeam system means more advanced treatments can be delivered in shorter times, potentially enabling a resumption of normal working patterns.

"We have been forced to introduce shifts to keep pace with the patient needs, but TrueBeam will enable us to go back to a normal working day," says head of physics Sture Eklund, M.D. "It will also allow us to introduce advanced treatment techniques, such as stereotactic radiosurgery."

A 71-year-old local man with prostate cancer became the first patient to be treated on the device earlier this month, and many more have been treated since. "Our experience so far is that we're achieving high levels of precision, excellent image quality and very fast throughput," says Eklund.

TrueBeam was designed to treat cancer in a fast and precise manner, including tumors that move during treatment as the patient breathes in and out. Intended to advance the treatment of lung, breast, prostate, head and neck, and other types of cancer, it features technical innovations that dynamically synchronize imaging, patient positioning, motion management and treatment delivery. With its High Intensity Mode, the system can deliver very high doses quickly and accurately, more than twice as fast as earlier generations of technology.

Eklund said brain tumor patients were previously sent to Stockholm and lung and esophagus cancer patients to Uppsala for stereotactic radiotherapy treatments. But with TrueBeam, such patients can now receive stereotactic treatments at Vasteras, which serves a population of about 250,000.

"We are the only hospital offering radiotherapy treatments in this county and it is important for people not to have to travel long distances for treatment," he added. "One of our current machines was due for replacement and we had a choice to make – we could buy something cheaper, which could be obsolete in two or three years, or we could buy a much more advanced system which would see us through many more years. We opted for the latter."

TrueBeam can be used to deliver intensity-modulated radiotherapy (IMRT), which is a precise form of radiotherapy that shapes the treatment beam so that it matches the shape of the tumor in three dimensions. The device can also deliver RapidArc radiotherapy, which speeds up IMRT delivery by as much as a factor of eight.

Eklund said even carrying out IMRT has been a problem for the hospital in the past due to time constraints, but both RapidArc and stereotactic radiosurgery treatments would soon commence on the new system. "Our staff is delighted with TrueBeam," he added. "They find it very easy to use, very intuitive, and it takes this hospital's treatment capabilities to the next level."

For more information:

Related Content

more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Surgery and High-Dose SBRT Radiation Can Be Combined to Treat Kidney Cancer
News | Stereotactic Body Radiation Therapy (SBRT) | July 05, 2017
A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the...
Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system

Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system. Combined, these systems will allow for simultaneous radiation therapy delivery and high-field MR tumor monitoring.

Feature | Radiation Oncology | July 05, 2017 | By Jeff Zagoudis
Image-guided radiation therapy offers great potential to improve the efficiency of treating cancer patients by more...

Photo courtesy of RaySearch

Feature | Treatment Planning | July 05, 2017 | By Jeff Zagoudis
While radiation oncologists have a number of proven techniques at their disposal for treating patients, the reality is...
ASTRO Issues Guideline for Stereotactic Radiation Use in Early-Stage Lung Cancer
Feature | Lung Cancer | June 23, 2017
The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the use of...
Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer

IMAGE OF THE YEAR: Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer. Technology of dual-labeled PSMA-inhibitors for PET/CT imaging and fluorescence-guided intraoperative identification of metastases. This work might help to establish a new treatment regimen for more precise and sensitive pre-, intra- and post-therapeutic detection of prostate cancer.

Credit: Courtesy of A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center, Heidelberg, Germany; T. Simpfendörfer, B. Hadaschik, U. Haberkorn, Heidelberg University Hospital, Heidelberg, Germany; PET-image: Afshar-Oromieh et al., EJNMMI 2013; 40(4); STED-image: J. Matthias, German Cancer Research Center.

This study was supported by the VIP+ fund, Federal Ministry of Education & Research (BMBF), Germany.

Scientific Paper 531: “Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer.” A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center (DKFZ), Heidelberg, Germany; T. Simpfendörfer, B.  Hadaschik, U. Haberkorn, University Hospital, Heidelberg, Germany. Presented at SNMMI’s 64th Annual Meeting, June 10-14, 2017, Denver, Colo.

News | Prostate Cancer | June 15, 2017
In the battle against metastatic prostate cancer, the removal of lymph node metastases using image-guided surgery may...

Image courtesy of Elekta

News | Radiation Therapy | June 13, 2017
Radiation therapy (RT) using high-energy particles, like X-rays or electron beams, is a common and critical component...
News | Radiation Oncology | June 12, 2017
The alliance will study the feasibility of using CRnR’s converging x-ray lens technology as an effective radiotherapy...
stereotactic body radiation therapy (SBRT)
News | Stereotactic Body Radiation Therapy (SBRT) | June 12, 2017
The American Society for Radiation Oncology (ASTRO) issued a new clinical guideline for the use of stereotactic body...
Sponsored Content | Case Study | Radiation Therapy | June 08, 2017
Stereotactic body radiation therapy (SBRT) employs significantly higher per fraction radiation doses than conventional...
Overlay Init